1. Home
  2. NNVC vs CHSCO Comparison

NNVC vs CHSCO Comparison

Compare NNVC & CHSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNVC
  • CHSCO
  • Stock Information
  • Founded
  • NNVC 2005
  • CHSCO N/A
  • Country
  • NNVC United States
  • CHSCO United States
  • Employees
  • NNVC N/A
  • CHSCO N/A
  • Industry
  • NNVC Biotechnology: Pharmaceutical Preparations
  • CHSCO Farming/Seeds/Milling
  • Sector
  • NNVC Health Care
  • CHSCO Industrials
  • Exchange
  • NNVC Nasdaq
  • CHSCO Nasdaq
  • Market Cap
  • NNVC 22.5M
  • CHSCO N/A
  • IPO Year
  • NNVC N/A
  • CHSCO N/A
  • Fundamental
  • Price
  • NNVC $1.50
  • CHSCO $26.48
  • Analyst Decision
  • NNVC
  • CHSCO
  • Analyst Count
  • NNVC 0
  • CHSCO 0
  • Target Price
  • NNVC N/A
  • CHSCO N/A
  • AVG Volume (30 Days)
  • NNVC 251.7K
  • CHSCO N/A
  • Earning Date
  • NNVC 05-15-2025
  • CHSCO N/A
  • Dividend Yield
  • NNVC N/A
  • CHSCO N/A
  • EPS Growth
  • NNVC N/A
  • CHSCO N/A
  • EPS
  • NNVC N/A
  • CHSCO N/A
  • Revenue
  • NNVC N/A
  • CHSCO N/A
  • Revenue This Year
  • NNVC N/A
  • CHSCO N/A
  • Revenue Next Year
  • NNVC N/A
  • CHSCO N/A
  • P/E Ratio
  • NNVC N/A
  • CHSCO N/A
  • Revenue Growth
  • NNVC N/A
  • CHSCO N/A
  • 52 Week Low
  • NNVC $0.94
  • CHSCO N/A
  • 52 Week High
  • NNVC $2.55
  • CHSCO N/A
  • Technical
  • Relative Strength Index (RSI)
  • NNVC 62.79
  • CHSCO 53.88
  • Support Level
  • NNVC $1.34
  • CHSCO $26.03
  • Resistance Level
  • NNVC $1.44
  • CHSCO $26.34
  • Average True Range (ATR)
  • NNVC 0.09
  • CHSCO 0.20
  • MACD
  • NNVC 0.02
  • CHSCO 0.04
  • Stochastic Oscillator
  • NNVC 95.65
  • CHSCO 100.00

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About CHSCO CHS Inc. Class B Cumulative Redeemable Preferred Stock

CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).

Share on Social Networks: